4.3 Review

Long-term side effects of glucocorticoids

Journal

EXPERT OPINION ON DRUG SAFETY
Volume 15, Issue 4, Pages 457-465

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1517/14740338.2016.1140743

Keywords

glucocorticoids; immunosuppression; side effects; corticosteroids

Funding

  1. Alcon
  2. Aldeyra Therapeutics
  3. Bausch Lomb
  4. Clearside Biomedical
  5. Dompe Pharmaceutical
  6. Eyegate Pharma
  7. Icon
  8. Novartis
  9. pSivida
  10. Santen
  11. Xoma
  12. Allergan
  13. Scientific and Technological Research Council of Turkey

Ask authors/readers for more resources

Introduction: Glucocorticoids represent the standard therapy for reducing inflammation and immune activation in various diseases. However, as with any potent medication, they are not without side effects. Glucocorticoid-associated side effects may involve most major organ systems. Musculoskeletal, gastrointestinal, cardiovascular, endocrine, neuropsychiatric, dermatologic, ocular, and immunologic side effects are all possible.Areas Covered: This article analyzes English-language literature and provides an update on the most recent literature regarding side effects of systemic glucocorticoid treatment.Expert Opinion: The risk/benefit ratio of glucocorticoid therapy can be improved by proper use. Careful monitoring and using appropriate preventive strategies can potentially minimize side effects.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available